project id: TCGA-BRCA; case submitter id: TCGA-B6-A402; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.97; rna integrity number: 8.1; age at index: 47; days to birth: -17314; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1961; age at diagnosis: 17314; ajcc pathologic m: M0; ajcc pathologic n: N0 (i-); ajcc pathologic stage: Stage I; ajcc pathologic t: T1c; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2281.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1563; initial weight: 10.0; sample id: 6961fffe-50b4-4296-8390-196b6070f739; sample submitter id: TCGA-B6-A402-01A; portion id: 863bc770-357d-41ae-8838-13918bb404e8; portion submitter id: TCGA-B6-A402-01A-11; slide id: 45f6b344-fee5-4f83-ab34-4f1ba99e445d; slide submitter id: TCGA-B6-A402-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 90.0; section location: TOP;